These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 27576872)

  • 1. Neurocognitive function varies by IDH1 genetic mutation status in patients with malignant glioma prior to surgical resection.
    Wefel JS; Noll KR; Rao G; Cahill DP
    Neuro Oncol; 2016 Dec; 18(12):1656-1663. PubMed ID: 27576872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between tumor grade and neurocognitive functioning in patients with glioma of the left temporal lobe prior to surgical resection.
    Noll KR; Sullaway C; Ziu M; Weinberg JS; Wefel JS
    Neuro Oncol; 2015 Apr; 17(4):580-7. PubMed ID: 25227126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of IDH1 mutation on the structural connectome in malignant astrocytoma.
    Kesler SR; Noll K; Cahill DP; Rao G; Wefel JS
    J Neurooncol; 2017 Feb; 131(3):565-574. PubMed ID: 27848136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological malignant progression of grade II and III gliomas correlated with IDH1/2 mutation status.
    Ohno M; Narita Y; Miyakita Y; Okita Y; Matsushita Y; Yoshida A; Fukushima S; Ichimura K; Kayama T; Shibui S
    Brain Tumor Pathol; 2012 Oct; 29(4):183-91. PubMed ID: 22790483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive functioning in patients with glioma of the left and right temporal lobes.
    Noll KR; Ziu M; Weinberg JS; Wefel JS
    J Neurooncol; 2016 Jun; 128(2):323-31. PubMed ID: 27022915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of isocitrate dehydrogenase 1 mutation in 97 patients with glioma.
    Zhou YX; Wang JX; Feng M; Sun CM; Sun T; Chen GL; Du ZW
    J Mol Neurosci; 2012 Jul; 47(3):442-7. PubMed ID: 22113362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection.
    Beiko J; Suki D; Hess KR; Fox BD; Cheung V; Cabral M; Shonka N; Gilbert MR; Sawaya R; Prabhu SS; Weinberg J; Lang FF; Aldape KD; Sulman EP; Rao G; McCutcheon IE; Cahill DP
    Neuro Oncol; 2014 Jan; 16(1):81-91. PubMed ID: 24305719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma.
    Raghunathan A; Olar A; Vogel H; Parker JR; Coventry SC; Debski R; Albarracin CT; Aldape KD; Cahill DP; Powell SZ; Fuller GN
    Ann Diagn Pathol; 2012 Aug; 16(4):255-9. PubMed ID: 22445362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avoiding New Biopsies by Identification of IDH1 and TERT Promoter Mutation in Nondiagnostic Biopsies From Glioma Patients.
    Barritault M; Picart T; Poncet D; Fenouil T; d'Hombres A; Gabut M; Guyotat J; Jouanneau E; Ameli R; Joubert B; Streichenberger N; Vasiljevic A; Honnorat J; Meyronet D; Ducray F
    Neurosurgery; 2020 Sep; 87(4):E513-E519. PubMed ID: 32107549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in Functional Connectomics Associated With Neurocognitive Changes Following Glioma Resection.
    Noll KR; Chen HS; Wefel JS; Kumar VA; Hou P; Ferguson SD; Rao G; Johnson JM; Schomer DF; Suki D; Prabhu SS; Liu HL
    Neurosurgery; 2021 Feb; 88(3):544-551. PubMed ID: 33080024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative and Quantitative Analysis of IDH1 Mutation in Progressive Gliomas by Allele-Specific qPCR and Western Blot Analysis.
    Perrech M; Dreher L; Röhn G; Stavrinou P; Krischek B; Toliat M; Goldbrunner R; Timmer M
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819828396. PubMed ID: 30943868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testing.
    Kim BYS; Jiang W; Beiko J; Prabhu SS; DeMonte F; Gilbert MR; Sawaya R; Aldape KD; Cahill DP; McCutcheon IE
    J Neurooncol; 2014 Jun; 118(2):405-412. PubMed ID: 24777756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IDH1 status is significantly different between high-grade thalamic and superficial gliomas.
    Zuo M; Li M; Chen N; Yu T; Kong B; Liang R; Wang X; Mao Q; Liu Y
    Cancer Biomark; 2017 Aug; 20(2):183-189. PubMed ID: 28869450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular subtypes of glioma identified by genome-wide methylation profiling.
    Kloosterhof NK; de Rooi JJ; Kros M; Eilers PH; Sillevis Smitt PA; van den Bent MJ; French PJ
    Genes Chromosomes Cancer; 2013 Jul; 52(7):665-74. PubMed ID: 23629961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of IDH1 Mutation Status in Glioblastoma Using Machine Learning Technique Based on Quantitative Radiomic Data.
    Lee MH; Kim J; Kim ST; Shin HM; You HJ; Choi JW; Seol HJ; Nam DH; Lee JI; Kong DS
    World Neurosurg; 2019 May; 125():e688-e696. PubMed ID: 30735871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression Profile Analysis of Zinc Transporters (ZIP4, ZIP9, ZIP11, ZnT9) in Gliomas and their Correlation with IDH1 Mutation Status.
    Kang X; Chen R; Zhang J; Li G; Dai PG; Chen C; Wang HJ
    Asian Pac J Cancer Prev; 2015; 16(8):3355-60. PubMed ID: 25921144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IDH1 mutation may not be prognostically favorable in glioblastoma when controlled for tumor location: A case-control study.
    Paldor I; Drummond KJ; Kaye AH
    J Clin Neurosci; 2016 Dec; 34():117-120. PubMed ID: 27522495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between preoperative neurocognitive status and IDH1 mutation status in high-grade gliomas.
    Liouta E; Kalyvas AV; Komaitis S; Drosos E; Koutsarnakis C; García-Gómez JM; Juan-Albarracín J; Katsaros V; Kalamatianos T; Argyrakos T; Stranjalis G
    Neurooncol Pract; 2023 Apr; 10(2):132-139. PubMed ID: 36970174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DZIP3 is a key factor to stratify IDH1 wild-type lower-grade gliomas.
    Liang T; Zhou X; Li P; You G; Wang F; Wang P; Feng E
    Aging (Albany NY); 2020 Nov; 12(24):24995-25004. PubMed ID: 33229627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.